Cover Image

Medicines pricing and reimbursement: innovation, competitiveness, and access

Saved in:

Bibliographic Details
Main Authors:	Adriana M. IVAMA-BRUMMELL (Author), Daniella PINGRET-KIPMAN (Author), Claudia S. OSORIO- (Author), Jaime ESPÍN (Author), Vania C. CANUTO-SANTOS (Author), Romilson A. VOLOTÃO (Author), Augusto A. GUERRA-JUNIOR (Author), Gabriela B. MOSEGUI (Author)
Format:	Book
Published:	Sociedade Brasileira de Farmácia Hospitalar e Serviços de Saúde, 2022-03-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Medicines regulation, pricing and reimbursement in Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

The regulatory, evaluation, pricing and reimbursement pathway for medicines in the UK: combining innovation and access
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Pharmaceutical Pricing and Reimbursement Policies: lessons learnt and perspectives for Brazil
by: Adriana M. IVAMA-BRUMMELL, et al.
Published: (2022)

Pricing and reimbursement mechanisms for advanced therapy medicinal products in 20 countries
by: Juan Carlos Rejon-Parrilla, et al.
Published: (2023)

Access to innovative drugs and the National Reimbursement Drug List in China: Changing dynamics and future trends in pricing and reimbursement
by: Bérengère Macabeo, et al.
Published: (2023)

Pharmaceutical regulation, pricing, coverage and policy reform in the United States of America
by: Mariana P. SOCAL, et al.
Published: (2022)

Promoting Access to Innovative Anticancer Medicines: A Review of Drug Price and National Reimbursement Negotiation in China
by: Xia Mingge MPH, et al.
Published: (2023)

Medicines pricing and reimbursement in Canada
by: Chris BONNETT, et al.
Published: (2022)

Italy - a study case of medicines pricing and reimbursement
by: Valdete A. MELO, et al.
Published: (2022)

Challenges and opportunities for pharmaceutical pricing and reimbursement policies
by: Sabine Vogler, et al.
Published: (2015)

Pharmaceutical pricing and reimbursement policies: perspectives for the future
by: Andrew L Gray
Published: (2015)

Assessing the Consequences of External Reference Pricing for Global Access to Medicines and Innovation: Economic Analysis and Policy Implications
by: András Incze, et al.
Published: (2022)

Balancing medical innovation and affordability in the new healthcare ecosystem in China: Review of pharmaceutical pricing and reimbursement policies
by: Vivian Chen, et al.
Published: (2023)

Pricing and Reimbursement of Biosimilars in Central and Eastern European Countries
by: Paweł Kawalec, et al.
Published: (2017)

Drug pricing and reimbursement decision making systems in Mongolia
by: Gereltuya Dorj, et al.
Published: (2017)

Reporting reimbursement price decisions for onco-hematology drugs in Spain
by: David Elvira, et al.
Published: (2023)

Approval, reimbursement and pricing of high-cost cancer medicines in Australia
by: Agnes Vitry
Published: (2015)

Abstracts from the 4th International PPRI Conference 2019: Medicines access challenge - The value of pricing and reimbursement policies
Published: (2019)

Reimbursement of combined antihypertensive medicenes in Ukraine: aspects of inclusion and external reference pricing
by: A. O. Gonchar, et al.
Published: (2022)

Marketing authorisation and pricing of FDA-approved cancer drugs in Brazil: a retrospective analysisResearch in context
by: Adriana M. Ivama-Brummell, et al.
Published: (2023)

Pharmaceutical pricing and reimbursement policies in Algeria, Morocco, and Tunisia: comparative analysis
by: Hajer Dahmani, et al.
Published: (2023)

Adapting pharmaceutical reimbursement policies to manage spending on high-priced drugs
by: Elizabeth Docteur, et al.
Published: (2015)

A comparative analysis of pricing and reimbursement systems between Italy and Bulgaria
by: Carmen Cannavale, et al.
Published: (2024)

Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis
by: Kyung-Bok Son
Published: (2020)

Reimbursement measures in European countries - findings of a bibliometric literature review
by: Sabine Vogler, et al.
Published: (2015)

Drug pricing and reimbursement information management: processes and decision making in the global economy
by: Dimitrios Tsourougiannis
Published: (2017)

Consumption and cost trends of EGFR TKIs: influences of reimbursement and national price negotiation
by: Di Wu, et al.
Published: (2022)

Critical Reflections on Reimbursement and Access of Advanced Therapies
by: Steven Simoens, et al.
Published: (2022)

A proportional rule for setting reimbursement prices of new drugs and its mathematical consistency
by: Afschin Gandjour
Published: (2020)

Has Competition Lowered Hospital Prices?
by: Jack Zwanziger, et al.
Published: (2005)

Description of the use of multicriteria to support pricing and reimbursement decisions by European health technology assessment bodies
by: David Elvira, et al.
Published: (2021)

Cell and gene therapy regulatory, pricing, and reimbursement framework: With a focus on South Korea and the EU
by: SungKyung Lee, et al.
Published: (2023)

Orphan drugs' clinical uncertainty and prices: Addressing allocative and technical inefficiencies in orphan drug reimbursement
by: Hans-Georg Eichler, et al.
Published: (2023)

A Comparative Analysis of Pricing and Reimbursement of Cystic Fibrosis Transmembrane Conductance Regulator Modulators in Europe
by: Khadidja Abdallah, et al.
Published: (2021)

Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, et al.
Published: (2010)

Will a Fixed Price Reimbursement Policy for Statins be Cost-Effective for Turkey's Health Care System?
by: Guvenc Kockaya, MD, et al.
Published: (2010)

Pricing of Consumer Innovations
by: Ebbing, Tobias
Published: (2022)

Pricing of Consumer Innovations
by: Ebbing, Tobias
Published: (2022)

Pricing of Consumer Innovations
by: Ebbing, Tobias
Published: (2022)

Health Technology Assessment in Portugal: health policies, methodologies and emerging challenges
by: Sónia CALDEIRA, et al.
Published: (2022)